Persistently high energy prices are keeping inflation pressure in focus and central banks on alert, which leaves a lot of uncertainty around interest rates. That uncertainty can rattle earnings driven stories, but it also shines a light on cash rich companies that markets may be overlooking. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that currently appear mispriced on cash flow potential.
The three stocks covered below are just a starting sample, since the full cash flow screen surfaced 26 more companies that currently show similarly interesting DCF based mispricings that are not discussed here. To identify and analyze the setups that best match your style, head straight to the Undervalued Stocks Based On Cash Flows screener.
Entero Healthcare Solutions (NSEI:ENTERO)
Overview: Entero Healthcare Solutions is a Mumbai based distributor that connects pharmaceutical companies and medical device makers with pharmacies, hospitals and clinics across India, handling imports, central warehousing, redistribution and last mile delivery. Its healthcare product distribution and Entero Surgicals private label range create recurring, transaction driven cash flows that align closely with the Undervalued Stocks Based On Cash Flows theme.
Operations: Entero Healthcare generates all of its ₹71.3 billion revenue from trading pharmaceutical and surgical products in India.
Market Cap: ₹61.0 billion
Entero Healthcare Solutions may be of interest if you want exposure to India’s healthcare demand through a cash generative distribution platform that SWS currently values well above the market price. The company’s nationwide network, private label Entero Surgicals products and expanding presence in higher margin devices and specialty pharma help support recurring cash flows, while recent quarterly results show a revenue and earnings base backing that view. At the same time, thin profit margins, reliance on acquisitions and competition from e pharmacy and quick commerce players keep execution risk significant. If management continues to improve efficiency and funding discipline, investors who understand these trade offs may want to examine the current valuation gap more closely.
Entero Healthcare Solutions looks like a cash engine that some investors may be underestimating, given its distribution reach and private label push. See how the DCF valuation analysis for Entero Healthcare Solutions lines up with thin margins and acquisition risk that could shift the story.
Build your own cash rich shortlist around Entero Healthcare Solutions
Entero Healthcare Solutions and the two other stocks in this article all came from a single screen, but the real advantage is in shaping your own filters. Use our flexible Screener to blend valuation, cash flows, balance sheet strength and risks around your style, or jump straight into any of our curated Investing Ideas.
M & B Engineering (NSEI:MBEL)
Overview: M & B Engineering is an Ahmedabad based engineering company that designs, manufactures and installs pre engineered metal buildings, self supported steel roofing and complex steel structures for projects such as bridges, flyovers and power plants in India and overseas. This contract driven pre engineered building and structural steel business is the main link to the Undervalued Stocks Based On Cash Flows theme, because large infrastructure and industrial projects can support relatively predictable cash flows over the life of each contract.
Operations: M & B Engineering generates its ₹13.1 billion revenue entirely from pre engineered buildings, structural steels, steel roofing and related components.
Market Cap: ₹16.2 billion
Investors looking at M & B Engineering are essentially weighing a company whose core pre engineered buildings and structural steel work creates contract backed cash flows against a market price that SWS currently values well below fair value on a DCF basis. Recent results, including Q1 2026 revenue of ₹2,961.8 million and net income of ₹219.02 million, plus ongoing capacity expansion at the Sanand heavy structural plant, indicate a business building on that cash flow base. At the same time, thinner profit margins, dividends that are not well covered by free cash flow and reliance on external borrowing rather than customer deposits all add financial risk that could bite if project timing or credit conditions turn less favorable.
M & B Engineering’s contract backed cash flows and SWS valuation gap raise a clear question for investors. See how the 3 key rewards and 1 important warning sign frames both the upside and the funding risks that could change the endgame.
Balrampur Chini Mills (NSEI:BALRAMCHIN)
Overview: Balrampur Chini Mills is a Kolkata based sugar producer whose main cash flow engine is sugar manufacturing and sale, supported by molasses, ethanol and other distillery products, bagasse based power generation and a smaller push into polylactic acid bioplastics and allied agri inputs. This integrated sugar, distillery and power model gives the company multiple linked revenue streams that feed directly into the Undervalued Stocks Based On Cash Flows theme.
Operations: Balrampur Chini Mills generates most of its revenue from sugar at ₹55.6 billion, with ₹18.0 billion from the distillery segment, ₹410.6 million from polylactic acid and ₹126.4 million from other activities, partly offset by ₹10.5 billion of inter segment revenue.
Market Cap: ₹138.5 billion
Balrampur Chini Mills may be worth a closer look for investors seeking exposure to sugar linked cash flows, with additional potential from ethanol and emerging bioplastics. The stock currently trades below SWS’s DCF estimate. The core sugar, distillery and bagasse power operations contribute to recurring cash generation, and analysts have published expectations of earnings and revenue growth from this base. The trade off is meaningful, with earnings closely tied to government policy on ethanol and sugar pricing, and a large, debt funded PLA project that could strain cash flows if ramp up or demand is weaker than anticipated. Investors who are comfortable weighing these policy and execution risks against the potential cash flow benefits may consider Balrampur Chini Mills for a value oriented watchlist.
Balrampur Chini Mills appears to be a sugar and ethanol cash story that many investors still treat as routine. See how the 2 key rewards and 2 important warning signs (1 is major!) reveals what changing policy and that large PLA project might really mean
Seeking Alternatives Before Everyone Else?
Fresh stock themes can move from quiet accumulation to breakout momentum fast. Scan these ideas while they are still under the radar for now and consider them early.
- Target steadier portfolios by reviewing a curated 295 resilient stocks with low risk scores that could help you stay in the game when volatility spikes and others get caught off guard.
- Explore the data center and chip build out by scanning a hand picked 56 AI infrastructure stocks before capital focuses on the same capacity stories and valuations become more widely discussed.
- Consider positioning for a potential next leg in commodities by checking a focused 30 elite gold producer stocks while these producers are still priced as if momentum might not last.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com